Objective: This paper is to explore the relationship between IL-2, IL-6, IL-8 and the development of hyperthyroidism and subclinical hyperthyroidism. Methods The serum levels of IL-2, IL-6 and IL-8 were determined in 251 cases of hyperthyroidism, 242 cases of subclinical hyperthyroidism and 130 cases of normal control. Results The level of IL-2 in hyperthyroidism group was significantly lower than that in the control group (P<0.01), and the levels of IL-6 and IL-8 were significantly higher than those in the control group (P<0.01); The level of IL-2 in subclinical hyperthyroidism group was lower than that in the control group (P<0.05), and the levels of IL-6 and IL-8 were higher than those in the control group (P<0.05). The level of IL-2 in hyperthyroidism group was lower than that in subclinical hyperthyroidism group, and the level of IL-6 and IL-8 were higher than those in subclinical hyperthyroidism group. The two groups of IL-2 were negatively correlated with serum FT3, FT 4, TT3, and TT4, and IL-6 and IL-8 were positively correlated with serum FT3, FT 4, TT3, and TT4. Conclusions IL-2, IL-6, and IL-8 all participated in the development process of hyperthyroidism and subclinical hypothyroidism, which contributed to the early discovery of subclinical hyperthyroidism.
Published in | Science Journal of Public Health (Volume 7, Issue 5) |
DOI | 10.11648/j.sjph.20190705.14 |
Page(s) | 159-162 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2019. Published by Science Publishing Group |
Hypothyroidism, Subclinical Hypothyroidism, IL-2, IL-6, IL-8
[1] | Hou Zhenjiang, Zhang Jingyu, Bian Yunzhuo, et al. Changes of serum lipid level, its ratio and cystatin C level in patients with hyperthyroidism and subclinical hyperthyroidism [J]. Shandong Medical Journal, 2017, 57 (39): 91-93. |
[2] | Yu Tao. Dose effect of compound hyperthyroidism tablet in treatment of subclinical hyperthyroidism [J]. China Medicine and Pharmacy, 2017, 7 (2): 34-36. |
[3] | Lu Zaiying, Zhong nanshan. Internal Medicine [M]. Beijing 7th Edition: People's Health Publishing House, 2012: 714. |
[4] | Collet TH, Gussekloo J, Bauer DC, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality [J]. Arch Intern Med, 2012, 172 (10): 799-809. |
[5] | Xu Xiaojin, Geng Jin, Hu Ting-ting, et al. Effect of subclinical hyperthyroidism on adverse cardiovascular events in patients with type 2 diabetes mellitus [J]. Shandong Medical Journal, 2017, 57 (14): 68-71. |
[6] | Pang Aiping. The characteristics of patients with Graves disease complicated with hyperthyroidism heart disease and the clinical significance of related biochemical indicators [D]. Guangxi Medical University, 2018. |
[7] | Wu Yajun, Huang Yong-de. Peptic ulcer with Hp infection and its relationship with serum IL-6, IL-8 and IL-2 [J]. Clinical Journal of Medical Officers, 2017, 45 (01): 38-41. |
[8] | Li-Chao, Guo Qi. Changes of Serum IL-1β, IL-2, IL-6, IL-8 and TNF-α Levels in patients with epilepsy and clinical significance [J]. Journal of Preventive Medicine of Chinese People's Liberation Army, 2018, 36 (03): 375-377+385. |
[9] | Ma Xiaolan, Wu Xuecheng, Zhang Shiyi. Observation of serum TNF, IL-6 and IL-8 levels in patients with hyperthyroidism and hypothyroidism [J]. Journal of Radioimmunology, 2002, 15 (3): 166. |
[10] | Guo Jianlian, Liu Huina, Lu Long-kun, et al. The relationship between the levels of serum IL-2, IL-6, IL-8, TNF-α and bloodstream infection in critically ill patients [J]. Current Immunology, 2018, 38 (02): 120-123. |
[11] | Zhang Yunming, Song Mingqiang. Changes of IL-2, IL-6, TNF concentration after 131I therapy in patients with hyperthyroidism from Graves’ disease [J]. Guide of China Medicine, 2013, 11 (2): 8-9. |
[12] | Gao Haibo, Zhang Yawei, Hu Jiankang, et al. Effect of IL-2 and IL-6 levels on prognosis of 131 iodine treatment in Graves' patients [J]. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, 2016, (6): 716-718. |
[13] | Wang Xiaoying, Gaolin, Liao Xin. et al. Relevance study between serum levels of Visfatin, IL-6 and TNF-alpha and thyroid function in patients with Graves' disease [J]. Guizhou Medical Journal, 2018, 42 (02: 162-163). |
[14] | Shen J, Li Z, Li W, et a1. Thl, Th2, and Thl7 cytokine in—volvement in thyroid associated ophthalmopathy [J]. DisMarkers, 2015, 10 (7): 638-643. |
[15] | Wei-Feng, Jiao Yanxiang, Guang Yan Qin, et al. Influence of different thyroid functional statuses on human serum IL-8, TNF Levels [J]. Journal of Radioimmunology, 2003 (04): 193-195. |
[16] | Zhao Jiwei, Yang Lijuan, Sun Xuefeng. Advances in the study of the relationship between thyroid tumors and cytokines IL-4, IL-10, IFN-gamma and IL-17 [J]. Journal of Hebei North University (Natural Science Edition), 2015, 31 (3): 102-105. |
[17] | Wang Junfang, Zhang Wei, Li Jing-li, et al. Effect of selenium on serum levels of TPOAb and TGAb in patients with Graves' disease [J]. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease, 2013, 11 (04): 502-503. |
APA Style
Li Hongyan, Zhang Chunhui, Wang Hongsheng, Xu Qian. (2019). Significance of Serum IL-2, IL-6 and IL-8 Detection in Patients with Hyperthyroidism and Subclinical Hyperthyroidism. Science Journal of Public Health, 7(5), 159-162. https://doi.org/10.11648/j.sjph.20190705.14
ACS Style
Li Hongyan; Zhang Chunhui; Wang Hongsheng; Xu Qian. Significance of Serum IL-2, IL-6 and IL-8 Detection in Patients with Hyperthyroidism and Subclinical Hyperthyroidism. Sci. J. Public Health 2019, 7(5), 159-162. doi: 10.11648/j.sjph.20190705.14
AMA Style
Li Hongyan, Zhang Chunhui, Wang Hongsheng, Xu Qian. Significance of Serum IL-2, IL-6 and IL-8 Detection in Patients with Hyperthyroidism and Subclinical Hyperthyroidism. Sci J Public Health. 2019;7(5):159-162. doi: 10.11648/j.sjph.20190705.14
@article{10.11648/j.sjph.20190705.14, author = {Li Hongyan and Zhang Chunhui and Wang Hongsheng and Xu Qian}, title = {Significance of Serum IL-2, IL-6 and IL-8 Detection in Patients with Hyperthyroidism and Subclinical Hyperthyroidism}, journal = {Science Journal of Public Health}, volume = {7}, number = {5}, pages = {159-162}, doi = {10.11648/j.sjph.20190705.14}, url = {https://doi.org/10.11648/j.sjph.20190705.14}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjph.20190705.14}, abstract = {Objective: This paper is to explore the relationship between IL-2, IL-6, IL-8 and the development of hyperthyroidism and subclinical hyperthyroidism. Methods The serum levels of IL-2, IL-6 and IL-8 were determined in 251 cases of hyperthyroidism, 242 cases of subclinical hyperthyroidism and 130 cases of normal control. Results The level of IL-2 in hyperthyroidism group was significantly lower than that in the control group (P<0.01), and the levels of IL-6 and IL-8 were significantly higher than those in the control group (P<0.01); The level of IL-2 in subclinical hyperthyroidism group was lower than that in the control group (P<0.05), and the levels of IL-6 and IL-8 were higher than those in the control group (P<0.05). The level of IL-2 in hyperthyroidism group was lower than that in subclinical hyperthyroidism group, and the level of IL-6 and IL-8 were higher than those in subclinical hyperthyroidism group. The two groups of IL-2 were negatively correlated with serum FT3, FT 4, TT3, and TT4, and IL-6 and IL-8 were positively correlated with serum FT3, FT 4, TT3, and TT4. Conclusions IL-2, IL-6, and IL-8 all participated in the development process of hyperthyroidism and subclinical hypothyroidism, which contributed to the early discovery of subclinical hyperthyroidism.}, year = {2019} }
TY - JOUR T1 - Significance of Serum IL-2, IL-6 and IL-8 Detection in Patients with Hyperthyroidism and Subclinical Hyperthyroidism AU - Li Hongyan AU - Zhang Chunhui AU - Wang Hongsheng AU - Xu Qian Y1 - 2019/09/27 PY - 2019 N1 - https://doi.org/10.11648/j.sjph.20190705.14 DO - 10.11648/j.sjph.20190705.14 T2 - Science Journal of Public Health JF - Science Journal of Public Health JO - Science Journal of Public Health SP - 159 EP - 162 PB - Science Publishing Group SN - 2328-7950 UR - https://doi.org/10.11648/j.sjph.20190705.14 AB - Objective: This paper is to explore the relationship between IL-2, IL-6, IL-8 and the development of hyperthyroidism and subclinical hyperthyroidism. Methods The serum levels of IL-2, IL-6 and IL-8 were determined in 251 cases of hyperthyroidism, 242 cases of subclinical hyperthyroidism and 130 cases of normal control. Results The level of IL-2 in hyperthyroidism group was significantly lower than that in the control group (P<0.01), and the levels of IL-6 and IL-8 were significantly higher than those in the control group (P<0.01); The level of IL-2 in subclinical hyperthyroidism group was lower than that in the control group (P<0.05), and the levels of IL-6 and IL-8 were higher than those in the control group (P<0.05). The level of IL-2 in hyperthyroidism group was lower than that in subclinical hyperthyroidism group, and the level of IL-6 and IL-8 were higher than those in subclinical hyperthyroidism group. The two groups of IL-2 were negatively correlated with serum FT3, FT 4, TT3, and TT4, and IL-6 and IL-8 were positively correlated with serum FT3, FT 4, TT3, and TT4. Conclusions IL-2, IL-6, and IL-8 all participated in the development process of hyperthyroidism and subclinical hypothyroidism, which contributed to the early discovery of subclinical hyperthyroidism. VL - 7 IS - 5 ER -